Hence, we hypothesized that the abnormal activation EGFR and its downstream pathways may induce PTSs in pancreatic acinar cells and the accumulation/activation of HSF1 in pancreatic cancer tumorigenesis may be a passive response of the cells against to increasing PTSs. The gene discussed is HSF1; the disease is familial pancreatic carcinoma.